Shedding new light on cytokine signaling through molecular engineering
Project Number1R35GM147179-01
Contact PI/Project LeaderMENDOZA, JUAN LUIS
Awardee OrganizationUNIVERSITY OF CHICAGO
Description
Abstract Text
Project Summary/Abstract
Cytokine signaling is essential to the initiation of the immune response against microbial infection and cancer.
The immune system is composed of two mechanisms of defense defined as the innate and adaptive immune
systems, both of which critically rely on cytokine signaling to function. The innate immune system acts early
during an infection or cancer and includes the type I IFN response. The adaptive immune system becomes fully
active after approximately seven days. Although this response is delayed relative to the innate system, the time
is needed to mount a T-cell response that is potent and specific. Interleukin-2 and interferon gamma are
examples of cytokines that shape the response of the adaptive immune system. There are dozens of other
cytokine families that each play an important role in the immune system including hematopoiesis, inflammation,
apoptosis as well as many others. Understanding how cytokines signal, the genes they induce, and their
functions are critical to understanding human health and disease. Recent examples of engineered cytokines
demonstrate that tuning of cytokine signaling can drastically alter a cytokine’s response and may offer promising
new therapeutic approaches. In this proposal, we aim to use protein engineering technologies to fill the large
gaps in knowledge of cytokine signaling which may reveal new targets and approaches for therapeutic
intervention.
The paradigm of cytokine signaling is that cytokines drive the dimerization of cytokine receptors. Janus
kinases (JAKs) are believed to be constitutively bound to the cytokine receptors. Upon receptor dimerization, the
JAKs cross phosphorylate each other as well as the receptors. Signal transducers and activators of transcription
(STATs) bind to the phosphorylated receptors, are then phosphorylated, dimerize, and translocate to the nucleus
to elicit gene and functional responses. Recent tool development in our lab provides a streamlined approach to
characterize protein-protein interactions which occur intracellularly, challenge assumptions in the field, and
provide an opportunity to understand how every step in cytokine signaling contributes to cytokine signaling. We
aim to show how altering these interactions tune cytokine signaling and response gene and functional signature.
Public Health Relevance Statement
Narrative
Cytokine signaling is essential to immune function and is an area with great clinical therapeutic potential. Dozens
of cytokine families have different roles in the immune system which all signal through their specific combinations
Janus kinases (Jaks) and STAT proteins. We propose using biochemistry, biophysics, and protein engineering
to understand how the different cytokine receptor families interact with the Jaks and STATs which will identify
new targets for tuning cytokine signaling.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Adaptive Immune SystemApoptosisAreaBindingBiochemistryBiophysicsCell NucleusClinicalCytokine ReceptorsCytokine SignalingDefense MechanismsDimerizationDiseaseEngineeringFamilyGenesHealthHematopoiesisHumanImmune responseImmune systemInfectionInflammationInnate Immune SystemInterferon Type IIInterferonsInterleukin-2Janus kinaseKnowledgeLightMalignant NeoplasmsMolecularPlayProtein EngineeringProteinsRoleSTAT proteinShapesSignal TransductionSystemT cell responseTechnologyTherapeuticTherapeutic InterventionTimeadaptive immune responsecytokinedimerimmune functionmicrobialnovel therapeutic interventionprotein protein interactionreceptorresponsetool development
No Sub Projects information available for 1R35GM147179-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R35GM147179-01
Patents
No Patents information available for 1R35GM147179-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R35GM147179-01
Clinical Studies
No Clinical Studies information available for 1R35GM147179-01
News and More
Related News Releases
No news release information available for 1R35GM147179-01
History
No Historical information available for 1R35GM147179-01
Similar Projects
No Similar Projects information available for 1R35GM147179-01